| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |